Spyre Therapeutics, Inc. (SYRE) quarterly cash flow statement — complete operating, investing & financing history
Spyre Therapeutics, Inc. (SYRE) cash flow statement — 12-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -77.5M | -69.88M | -57.37M | -44.58M | -37.12M | -46.56M | -40.99M | -37.2M | -29.42M | -62.25M | -28.54M | -31.04M | -34.6M | -16.64M | -17.63M | -18.14M | -15.07M | -20.67M | -26.26M | -19.27M |
| Operating CF Margin % | - | - | - | -49.26% | - | - | - | - | - | - | - | - | - | -2419.04% | -8906.06% | -10797.62% | -8659.77% | -3307.68% | -1928.27% | -528.76% |
| Operating CF Growth % | -108.79% | -50.07% | -39.95% | -19.84% | -26.16% | 25.2% | -43.63% | -19.86% | 14.96% | -274.02% | -61.86% | -71.09% | -129.61% | 19.49% | 32.86% | 5.85% | 11.36% | -1092.94% | -34.48% | -12.47% |
| Net Income | -96.12M | -36.2M | -69M | -62.53M | -11.18M | -36.72M | -44.77M | -56.3M | -69.03M | -38.84M | -43.86M | -63.18M | -40.11M | -217.08M | -18.42M | -18.82M | -18.23M | -22.32M | -24.44M | -20.45M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -220K | 0 | 416K | 548K | 385K | 502K | 569K | 403K | 411K |
| Stock-Based Compensation | 14.17M | 13.51M | 12.81M | 9.81M | 9.57M | 9.38M | 8.86M | 9.22M | 13.1M | 8.68M | 13.84M | 17.27M | 4.79M | 1.91M | 1.71M | 1.43M | 1.57M | 2.02M | 2.1M | 2.09M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.71M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -4.08M | -38.26M | -1.42M | 10.41M | -41.44M | -10.18M | -4.51M | -917K | 16.16M | -2.94M | -1.99M | 18.66M | 8.68M | 192.14M | -105K | 28K | -33K | 131K | 78K | 186K |
| Working Capital Changes | 8.54M | -8.93M | 244K | -2.27M | 5.94M | -9.04M | -568K | 10.8M | 10.35M | -29.16M | 3.47M | -1.86M | -7.95M | 5.97M | -1.36M | -1.16M | 1.13M | -1.07M | -4.41M | -1.51M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 163K | 1.48M | -1.32M | 45K | 294K | -190K | 533K | -197K | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -163K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 3.78M | 30K | -3.18M | 858K | 3.75M | 23K | 4.97M | -20.48M | 1.93M | 6.63M | -4.3M | -783K | -1.04M | 661K | 1.38M | -3.5M | 2.21M | -1.01M | -338K | 1.46M |
| Cash from Investing | -3.8M | -297.9M | 56.58M | -247.41M | 25M | 79M | -61K | -170.54M | 42.74M | -120.52M | -104.96M | -35.27M | -97.63M | 6.76M | 17.75M | 14M | 16.5M | 750K | 25.76M | 9.66M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 0 | -37K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.57% | - | 2.72% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.47M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 40M | 30M | 0 | 0 | 7M | 0 | 0 | 0 | 0 | 0 | 15.47M | 15M | 3.51M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 2.02M | 432.6M | 12.26M | 312.81M | -4.64M | 731K | 125K | 225.6M | 12.78M | 360K | 172.16M | 163.61M | -12.53M | 209.99M | 10K | -8K | -130K | 42.8M | 12K | 80K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8K | -8K | -8K | -63K | -175K | -172K | -169K |
| Equity Issued (Net) | 35.12M | 455.98M | 12.43M | 312.88M | 491K | 848K | -117K | 224.62M | 11.54M | -169.34M | 338.41M | 169.39M | -12.64M | 210M | 0 | 0 | -105K | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -117K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -33.1M | -23.38M | -171K | -69K | -5.13M | -117K | 242K | 979K | 1.24M | 169.7M | -166.25M | -5.79M | 105K | 0 | 18K | 0 | 38K | 42.98M | 184K | 249K |
| Net Change in Cash | -79.28M | 64.82M | 11.46M | 20.82M | -16.76M | 33.17M | -40.93M | 17.84M | 26.11M | -182.41M | 38.66M | 97.32M | -144.78M | 200.12M | 137K | -4.1M | 1.24M | 22.81M | -515K | -9.52M |
| Free Cash Flow | -77.5M | -69.88M | -57.37M | -44.58M | -37.12M | -46.56M | -40.99M | -37.2M | -29.42M | -62.25M | -28.54M | -31.04M | -34.6M | -16.64M | -17.63M | -18.14M | -15.07M | -20.67M | -26.3M | -19.27M |
| FCF Margin % | - | - | - | -49.26% | - | - | - | - | - | - | - | - | - | -2419.04% | -8906.06% | -10797.62% | -8660.34% | -3307.68% | -1930.98% | -528.76% |
| FCF Growth % | -108.79% | -50.07% | -39.95% | -19.84% | -26.16% | 25.2% | -43.63% | -19.86% | 14.96% | -274.02% | -61.86% | -71.09% | -129.59% | 19.49% | 32.95% | 5.85% | 11.84% | -1107.46% | -31.63% | -6.27% |
| FCF per Share | -0.88 | -0.82 | -0.73 | -0.59 | -0.61 | -0.77 | -0.68 | -0.79 | -0.58 | -1.37 | -0.78 | -1.43 | -8.06 | -4.35 | -4.68 | -6.94 | -4.00 | -6.29 | -9.96 | -9.76 |
| FCF Conversion (FCF/Net Income) | 0.81x | 1.93x | 0.83x | 0.71x | 3.32x | 1.27x | 0.92x | 0.66x | 0.43x | 1.60x | 0.65x | 0.49x | 0.86x | 0.08x | 0.96x | 0.96x | 0.83x | 0.93x | 1.07x | 0.94x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |